EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase III)

Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy

Joseph W Rossano, Charles Canter, Cordula M Wolf, Andrew Papez, Marta Gambra, Randall M Bryant, Juan Alejos, Michael McCulloch, Georgia Sarquella Brugada, Matthew J Bock, Aamir Jeewa, F Bennett Pearce und 9 weitere

New England Journal of Medicine · 2026

DOI: 10.1056/nejmoa2601103 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, 2026. Verfasst von Joseph W Rossano und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia. Hauptthemen laut MEDLINE: Cardiac Myosins, Cardiomyopathy, Hypertrophic, Ventricular Outflow Obstruction, Left, Uracil. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Bristol Myers Squibb Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac MyosinsCardiomyopathy, HypertrophicVentricular Outflow Obstruction, LeftUracilBenzylaminesAdolescentFemaleHumansMaleDouble-Blind MethodValsalva ManeuverTreatment Outcome

Substanzen

Cardiac MyosinsMYK-461UracilBenzylamines

Autor:innen und Institutionen

  • Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia.
  • Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Department of Pediatrics, Washington University School of Medicine, St. Louis.
  • Department of Congenital Heart Defects and Pediatric Cardiology, TUM University Hospital German Heart Center, School of Medicine and Health, Technical University of Munich, Munich, Germany.
  • Division of Pediatric Cardiology, Phoenix Children's Hospital, Phoenix, AZ.
  • Department of Pediatric Cardiology, La Paz University Hospital, Madrid.

ORCID-Profile: Milind Y Desai

Förderung

  • Bristol Myers Squibb Foundation

Zitieren

APA

Rossano, J. W., Canter, C., Wolf, C. M., Papez, A., Gambra, M., Bryant, R. M., Alejos, J., McCulloch, M., Sarquella Brugada, G., Bock, M. J., Jeewa, A., Pearce, F. B., Desai, M. Y., Favatella, N., Javidialsaadi, A., Phung, V., Rano, T., Zhu, L., Dyme, J. L., …, & SCOUT-HCM Investigators (2026). Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2601103

Vancouver

Rossano JW, Canter C, Wolf CM, Papez A, Gambra M, Bryant RM, et al. Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy. New England Journal of Medicine. 2026. doi:10.1056/nejmoa2601103

BibTeX
@article{Rossano2026,
  author = {Rossano, Joseph W and Canter, Charles and Wolf, Cordula M and Papez, Andrew and Gambra, Marta and Bryant, Randall M and Alejos, Juan and McCulloch, Michael and Sarquella Brugada, Georgia and Bock, Matthew J and Jeewa, Aamir and Pearce, F Bennett and Desai, Milind Y and Favatella, Nicholas and Javidialsaadi, Atefeh and Phung, Van and Rano, Thomas and Zhu, Lin and Dyme, Joshua L and Mital, Seema and SCOUT-HCM Investigators, SCOUT-HCM Investigators},
  title = {Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy},
  journal = {New England Journal of Medicine},
  year = {2026},
  doi = {10.1056/nejmoa2601103}
}
Kostenlos starten →